DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Veralipride
Veralipride
The SULPYCO Method Using Sulpiride Integrated with an Atypical Adjuvant Therapy for Treating Depressive Syndrome: an Observational Study Amgad M
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
The Effects of Antipsychotic Treatment on Metabolic Function: a Systematic Review and Network Meta-Analysis
Enhancing the Low Oral Bioavailability of Sulpiride Via Fast Orally Disintegrating Tablets: Formulation, Optimization and in Vivo Characterization
SCP Achei Memantine for Alzheimers Disease Oct 2018
113.22 Kb
Drug and Medication Classification Schedule
Yo U Are P Ro H Ib Ited from M Aking Th Is P D F P U B Licly Availab Le. It Is
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
Exelon, INN-Rivastigmine
Stembook 2018.Pdf
Electronic Search Strategies
Review of Existing Classification Efforts
New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A
Levosulpiride Induced Parkinsonism and Other Movement Disorders
Drug/Substance Trade Name(S)
(2006.01) A61P 25/36 (2006.01) A61K 9/00 (2006.01) (21) International Application Number: PCT/US20 19/059852 (22) International Filing Date: 05 November 2019 (05
Supplemental Information
Top View
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Uniform Classification Guidelines for Foreign Substances, Version 7.00
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Effect of Sulpiride on Menopausal Hot Flashes: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
WORSENING of PARKINSONISM AFTER the USE of VERALIPRIDE for TREATMENT of MENOPAUSE Case Report
Email:
[email protected]
AC-001 154235-83-3 Ampalex AC-002 34381-68-5 Acebutolol Hydrochloride AC-003 5438-68-6 O-Acetyl Ma
Bioactive Compound Library Plus (96-Well)
Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule
Withdrawal Versus Continuation of Chronic Antipsychotic Drugs for Behavioural and Psychological Symptoms in Older People with Dementia (Review)
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Psychosocial Interventions for Reducing Antipsychotic Medication in Care Home Residents (Review)
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Association of Hydroxylmethyl Glutaryl Coenzyme a Reductase Inhibitors
AERC Drug Rule Appendices
Package Leaflet: Information for the User Tiaprid PMCS 100 Mg Tablets Tiapride Hydrochloride Read All of This Leaflet Carefully
Therapeutic Perspective on Tardive Syndrome with Special Reference to Deep Brain Stimulation
Antipsychotics for the Treatment of Sympathomimetic Toxicity: a Systematic Review Q ⇑ Nicholas J
Summary of Product Characteristics 1. Name Of
Restrictions in Use and Availability of Pharmaceuticals 2010 - 2018
Piperidine AC-002 34381-68-5 Acebutolol Hydrochlorid
Exelon, INN-Rivastigmine
Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: a Narrative Review